19 molecular profiling product manager jobs found

PerkinElmer Responsibilities Location Woburn, MassachusettsUS Job ID REQ-054941 Company Overview: Covaris, LLC (a PerkinElmer subsidiary) is a leading sample preparation solution provider in Biotechnology headquartered in Woburn, Massachusetts and has pioneered the Adaptive Focused Acoustics(AFA) technology platform, therebyrevolutionizing pre-analytical sample preparation in the world of Omics, such as genomics, proteomics, etc. As a global leader in sample preparation technologies for life sciences research and molecular diagnostics applications, Covaris has successfully been awarded the ISO 13485 Quality System Certification. This certification demonstrates our commitment to meeting the highest international standards for medical device quality management systems and ensuring the high quality of life science research data for research and innovation. Job Summary: As an Automation Associate within the Solutions Group at Covaris, you will play a pivotal role...

Biogen Job Description About This Role: The Head of Corporate Quality is responsible for creating and managing the Global Biogen Quality Management System (QMS). The main areas of focus include Quality Systems, internal and external audits for cGMP compliance (including external vendors and CMOs), IT Quality, Technical Product Complaints, and Central Knowledge Management (including documentation). This role is central to Quality and PO&T, managing risk, compliance performance, staying compliant with regulatory changes, and seeking opportunities to gain efficiency and effectiveness in the administration of PO&T's cGMP systems. Additionally, the role is accountable for preparing semi-annual executive-level updates on the state of Biogen's QMS and informing Executive Management of potential business risks due to a changing regulatory environment or systemic issues within the company. This role also serves as the principal liaison with the R&D Clinical Compliance...

Legend Biotech USA Legend Biotech is seeking a Viral Vector Principal Scientist as part of the Technical Development team based in Somerset, NJ. Role Overview This position will be responsible for supporting viral vector process development and GMP manufacturing for Legend's gene and cell therapy clinical pipeline. Reporting to the Associate Director of Viral Vector Sciences within the Technical Development team, this role will work closely with external CDMOs and internal cross-functional teams, including analytical, quality, and regulatory leads, to develop and deliver required viral vector material. The successful candidate will be a collaborative and flexible individual with viral vector, GMP manufacturing, and CDMO experience. Key Responsibilities Support process and analytical development and production of lentivirus and retrovirus at the research, process development, and GMP production scale for use in clinical cell and gene therapy project...

Fusion Pharmaceuticals Fusion Pharmaceuticals, a member of the AstraZeneca Group , is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; FPI-2059, a small molecule targeting neurotensin receptor 1 (NTSR1), currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. Fusion has a fully operational Good...

Fusion Pharmaceuticals Fusion Pharmaceuticals, a member of the AstraZeneca Group , is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; FPI-2059, a small molecule targeting neurotensin receptor 1 (NTSR1), currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. Fusion has a fully operational Good...

PerkinElmer Responsibilities Location(s) Woburn, Massachusetts Status Regular Job ID REQ-054933 Company Overview: Covaris, LLC (a PerkinElmer subsidiary) is a leading sample preparation solution provider in Biotechnology headquartered in Woburn, Massachusetts and has pioneered the Adaptive Focused Acoustics(AFA) technology platform, therebyrevolutionizing pre-analytical sample preparation in the world of Omics, such as genomics, proteomics, etc. As a global leader in sample preparation technologies for life sciences research and molecular diagnostics applications, Covaris has successfully been awarded the ISO 13485 Quality System Certification. This certification demonstrates our commitment to meeting the highest international standards for medical device quality management systems and ensuring the high quality of life science research data for research and innovation. Summary Covaris is seeking a Systems Engineering professional who, working with little or...

Biogen Company Description Biogen's Immunology Research Unit spans two key locations: Cambridge, MA, and our new West Coast Hub in South San Francisco. Our mission is to transform the lives of patients with severe immune-mediated diseases by developing novel targeted therapies with significant clinical impact, faster. We are seeking top talent to join us on this journey. Job Description About this Role: Biogen is seeking a scientific leader with deep immunology expertise and experience across a range of target biology and modalities in early discovery and development stage programs. This role involves defining and executing an iterative research strategy, identifying promising targets and therapeutic modalities, and developing novel hypotheses and experimental approaches to understand the molecular mechanisms underlying autoimmune indications. Staying abreast of the latest scientific advancements and translating knowledge into potential therapeutic concepts is critical....

Legend Biotech USA Role Overview Legend Biotech is seeking one In Vivo Pharmacology Intern as part of the In Vivo Pharmacology (IVP) of Preclinical/Early Drug Development (PCD/EDD) team based in Piscataway (and Somerset) site for our 2025 Summer Internship Program, which will run from June 9th, 2025, to August 15th, 2025. As a summer intern, we will instruct him/her the basic knowledge and concept of in vivo model study to support early R&D projects as well as hands-on skills to prepare samples or test articles for in vivo model study. Meanwhile, the intern will also learn the basic technology of some necessary assays using animal model study sample, such as FACS flowcytometry, ELISA-based cytokine profiling or ddPCR or qRT-PCR. The intern will perform a small scale independent sub-titled study from an ongoing in vivo model study to investigate some features of IVP and R&D team interest. The intern will analyze the data and draft a study report accordingly. Key...

Biogen Company Description Biogen's Immunology Research Unity is located across two geographic locations, Cambridge, MA and our new West Coast Hub, based in South San Francisco. We are specifically focused on transforming the lives of patients with severe immune-mediated diseases by developing novel targeted therapies with outsized clinical impact, faster. To accomplish this, we are seeking top talent to join us on our journey. Job Description About This Role: Biogen is seeking a scientific leader with a proven track record in team management, drug discovery, and development spanning a range of small and large molecule modalities, with a preference for small molecule drug discovery experience. The role requires defining and executing an iterative research strategy, identifying promising targets and therapeutic modalities, and developing novel hypotheses and experimental approaches to understand the molecular mechanisms underlying autoimmune indications. Staying abreast...

PerkinElmer Responsibilities Location(s) Springfield, Illinois, Austin, Texas, Baton Rouge, Louisiana, Bismarck, North Dakota, Columbia, South Carolina, Columbus, Ohio, Des Moines, Iowa, Frankfort, Kentucky, Harrisburg, Pennsylvania, Hartford, Connecticut, Indianapolis, Indiana, Remote Status Regular Job ID REQ-054806 The Company PerkinElmer is a global analytical services and solutions provider with offerings including the leading OneSource Field and Laboratory services business that serve the biopharma, food, environmental, safety and applied end markets to accelerate scientific outcomes. Since 1937, PerkinElmer has served as a trusted partner in laboratory analysis and management and today complements its service offerings with a broad portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents. With a dedicated team of more than 5,000 team members, the Company serves customers in more than 35 countries....

Fusion Pharmaceuticals Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in Phase 2 trials; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radiopharmaceutical manufacturing facility to meet...

Fusion Pharmaceuticals Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in Phase 2 trials; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. In addition, Fusion is pursuing combination programs between RCs and DNA Damage Response Inhibitors (DDRis) and immune-oncology agents. Fusion has a fully operational Good Manufacturing Practice (GMP) compliant state-of-the-art radiopharmaceutical manufacturing facility to meet...

Revvity Find Your Future at Revvity At Revvity, "impossible" is inspiration.Bringing together the power of Life Sciences and Diagnostics, we provide health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. Every day, our 11,000+ employees collaborate to pioneer groundbreaking solutions that enable our customers to improve health outcomes around the world. Product Portfolio Revvity's Dharmacon Reagents contain a full set of tools for the research of genes and their function. Technologies include synthetic and lentiviral CRISPR based products, siRNA, shRNA, cDNA/ORFs available as single-gene targeting reagents or collections (libraries) of reagents designed for screening in an Arrayed or Pooled format. Additionally, the Dharmacon catalog includes custom synthesized RNA and DNA oligonucleotides according to customer needs. Job Summary The Field Application Scientist will work...

Fusion Pharmaceuticals Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines. Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes but is not limited to: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. Fusion has multiple other pipeline programs that will soon be entering into early FIH trials. In addition, Fusion is pursuing combination programs between RCs and other therapeutic modalities including DNA Damage Response Inhibitors (DDRis) and...

Fusion Pharmaceuticals Fusion Pharmaceuticals, a member of the AstraZeneca Group, is a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines.Fusion connects alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha emitting payloads to tumors. Fusion’s clinical portfolio includes but is not limited to: FPI-2265 targeting prostate specific membrane antigen (PSMA) for metastatic castration resistant prostate cancer currently in a Phase 2 trial; FPI-1434 targeting insulin-like growth factor 1 receptor currently in a Phase 1 trial; and FPI-2068, a bispecific IgG-based EGFR-cMET targeted radioconjugate currently in a Phase 1 trial. Fusion has multiple other pipeline programs that will soon be entering into early FIH trials. In addition, Fusion is pursuing combination programs between RCs and other therapeutic modalities including DNA Damage Response Inhibitors (DDRis) and...

Alkermes, Inc. The Associate Director position is responsible for the technical leadership of cross-functional CMC Teams supporting small molecule program development from pre-nomination through commercialization. This individual will lead the integration of technical and regulatory strategies to set the overall CMC strategy to achieve the desired target product profile. This individual will represent the CMC Team as the primary point of contact to project teams and governance forums and will communicate regularly on key risks and challenges. The successful candidate will be an effective role model for the scientific/technical community in the company by effectively managing technical details and providing expert opinions. This is a highly collaborative role that requires successful collaboration with various functions to successfully move CMC projects forward. This is a hybrid role, 3 days/week in the office, based in Waltham, MA Responsibilities Major duties and...

Revvity Overview: EUROIMMUN U.S. (a Revvity Company), is one of the leading manufacturers of medical laboratory diagnostics worldwide. EUROIMMUN U.S. stands for innovation and is dedicated to improving the science of diagnostics and people's lives worldwide. Our extensive product portfolio and innovative technologies are designed to provide quick, accurate, and reliable diagnoses. More than 3,300 employees in 17 countries develop, produce, and sell test systems to support the diagnosis of diseases, as well as software and automation solutions for the performance and evaluation of these tests. Laboratories in over 140 countries use our assays and automation for autoimmune, infectious disease, allergy, antigen, and molecular testing. EUROIMMUN U.S. proudly prioritizes a people-centered culture, securing a spot among New Jersey's 2023 Top Places to Work. JOB SUMMARY: EUROIMMUN U.S. is seeking a multifaceted Field Application Scientist (FAS) to facilitate seamless...

Site Name: USA - Pennsylvania - Upper Providence Posted Date: Dec 31 2024 Key Responsibilities: We are seeking a highly motivated and talented Principal Scientist to join our Infectious Disease Research team with expertise in immunology and virology in Upper Providence, Pennsylvania. The Infectious Disease team is part of the Research Team within Vaccines/ID Research, which is one of the three therapeutic aligned research teams here at GSK. This position supports designing, executing, and analysing experiments to support drug discovery projects through to pre-clinical evaluation. The successful candidate will be responsible for running and leading preclinical in vitro/ in vivo studies aimed at exploring the HBV-specific immune and anti-viral responses, delivering a preclinical data package for validating immunomodulator(s) and/or antivirals for cure of chronic hepatitis B infection, and validating immunological and viral biomarkers to predict a functional cure. The...

Site Name: UK - Hertfordshire - Stevenage, USA - Pennsylvania - Upper Providence Posted Date: Nov 27 2024 Reporting to Vice President of Respiratory and Immunology Translational Unit (RITU), the Executive Director, Translational Sciences will be responsible for innovative disease area translational initiatives to inform therapy area and programme biomarker strategies that will increase the probability of success of preclinical to clinical transitions and allow for earlier and higher confidence project-related decisions. This will include generation of foundational data as well as disease biomarkers development and validation that allow timely deployment of tools/biomarkers that can support detection of Proof of Mechanism (PoM), signs of clinical efficacy, Proof of Concept (PoC), and pairing Mechanisms of Action (MoAs) with patient subtypes to predict rapid or complete responder populations in respiratory, immunology, or emerging specialities. The successful candidate will...